ReviewRSC advances2023
Pseudo-multicomponent reactions.
Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Unexpected Synthesis of a Furoxan Derivative from 3-Acetyl-2,4,6-Trimethylpyridine: Structural Characterization and Biological Evaluation.Molecules (Basel, Switzerland) · 2026Article
- Water-Mediated Arylation of an Imine Intermediate: A Catalyst- and Promoter-Free Three-Component Coupling in a Mortar Reactor.ACS omega · 2026Article
- Synthesis of Pyridines, Quinazolinones and Coumarins in Deep Eutectic Solvents: Principles, Methods and Applications.Molecules (Basel, Switzerland) · 2026Review
- Asparagine-modified magnetic graphene oxide as efficient green nanocatalyst for synthesis of chromenes and pyrano pyrazoles derivatives.Scientific reports · 2025Article
- Synthesis of Imidazolidin-2-ones fromMolecules (Basel, Switzerland) · 2025Article
- Isocyanate-based multicomponent reactions.RSC advances · 2024Review
- Green synthesis and investigation of antioxidant and antibacterial activity of new derivatives of chromenoazepines employing CuO/TiOMolecular diversity · 2024Article
- Recent trends for chemoselectivity modulation in one-pot organic transformations.RSC advances · 2024Review
- Recent developments using malononitrile in ultrasound-assisted multicomponent synthesis of heterocycles.Ultrasonics sonochemistry · 2024Review
- NiFeRSC advances · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Classical multicomponent reactions (MCRs) are domino-type one-pot processes in which three or more different reactants are combined sequentially in the same reactor to synthesize compounds containing all or almost all atoms coming from the reactants. Besides, pseudo-MCRs are also domino-type one-pot processes involving combinations of at least three reactants but in which at least one of them takes part in two or more reaction steps. In consequence, the products synthesized through pseudo-MCRs contain also all or almost all atoms but coming from two or more identical reactants. Thus, pseudo-MCRs differ from classical MCRs because the first ones appear to involve an assembly of a higher number of different components than those that are being truly assembled. However, pseudo-MCRs are also useful synthetic tools to generate libraries of complex compounds in few experimental steps, and although the repeated reactants may make them appear less diverse than classical MCRs, this can be offset by the higher number of reactants that can participate in this type of reaction. Overall, there are two types of pseudo-MCRs. The first are those in which the duplicated reagents participate in different steps of the corresponding reaction mechanism. The second kind of pseudo-MCRs are those in which one or more components react simultaneously with a main reagent containing two or more identical functional groups. These latter are known as repetitive pseudo-MCRs. Thus, the aim of the present review is to cover for the first time selected works mainly published in the last two decades about pseudo-MCRs and their repetitive versions toward the synthesis of novel, complex, and highly symmetrical molecules, often including their interesting applications in various fields of science and technology. The manuscript has been categorized considering the number of reagents participating in the corresponding pseudo-MCRs, aiming to give readers novel insights for their future investigations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.